Company / Net Income
Moleculin Biotech, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$26.0M
FY2025
5-year range
-$29.8M / -$15.9M
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income returned to growth in FY2025 after 2 years of decline, reaching -$26M.
Based on SEC 10-K filings.
-$26M in FY2025.
Improved from -$29M to -$26M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 12.5% year-over-year.
- Peak net income was recorded in FY2016.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$26.0M | +12.5% |
| FY2024 | -$29.8M | -2.6% |
| FY2023 | -$29.0M | -82.6% |
| FY2022 | -$15.9M | +8.4% |
| FY2021 | -$17.4M | -31.4% |
| FY2020 | -$13.2M | -11.2% |
| FY2019 | -$11.9M | -21.1% |
| FY2018 | -$9.8M | -149.7% |
| FY2017 | -$3.9M | -424.6% |
| FY2016 | -$748.4K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026